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目    的： 
To clarify the roles of PLD2 in tumor microenvironment for further understanding of its physiological 
functions in tumorigenesis. 
 
対象と方法：  
Subcutaneously transplant cancer cells into wild-type and Pld2-knockout mice to form tumors and 
analyze tumor-infiltrating T cells. 
Examine the in vitro proliferation of primary CD8+ T cells under co-stimulation of CD3/CD28. 
Examine the CD3/CD28-dependent activation of Erk and Ras in primary CD8+ T cells. 
 
結    果：  
Growth of the tumor formed by subcutaneously transplanted cancer cells is enhanced in Pld2-/- mice. 
Interestingly, the number of CD8+ T cells, which are known to induce cancer cell death, is significantly 
decreased in Pld2-/- tumor sections. In addition, CD3/CD28-stimulated proliferation of primary 
cultured CD8+ T cells isolated from the Pld2-/- spleen is significantly suppressed compared to that of 
WT CD8+ T cells. Furthermore, CD3/CD28-dependent activation of Erk1/2 and Ras and IL-2 
production are inhibited in Pld2-/- CD8+ T cells. 
 
考    察：  
Previous reports provide evidences for the central role of CD8+ T cells in anti-tumor immunity and are 
consistent with the notion that impaired CD8+ T cell infiltration into tumor microenvironment in Pld2-
/- mice promoted tumor growth. In the present study, we focused on the function of PLD2 in CD4+ and 
CD8+ T cells. However, PLD2 in other cell types may have effect on tumorigenesis.  
In dissecting the signaling pathway involved in PLD2-mediated T cell proliferation, we found that 
PLD2 is required for CD3/CD28-stimulated Ras activation and Erk phosphorylation in primary CD8+ 
T cells. Other reports showed that PLD2 can active Ras through the action of RasGEF. Taken together, 
it is reasonable to speculate that, upon TCR engagement of CD8+ T cells, PLD2 recruits a Ras GEF to 
the specific compartment such as the plasma membrane, inducing compartmentalized and temporal 
activation of Ras-Erk signaling to promote cell proliferation and survival. The detailed mechanism 
remains to be elucidated for the future analysis.  
 
結    論：  
The result obtained suggest that PLD2 promotes CD8+ T cell proliferation upon TCR engagement in 
the spleen through the activation of Ras-Erk pathway and IL-2 production, thereby potentiating the 
anti-tumor immune response. The findings revealed a novel function of PLD2 in the immune system, 
which may contribute to eliminate cancer cells. 
 
 
